Effects of Inflammatory Mediators on Airway Contraction
Author Information
Author(s): I. Gorenne, C. Labat, X. Norel, H. Sosse Alaoui, J.-P. Gascard, C. Brink
Primary Institution: CNRS URA 1159, Centre Chirurgical Marie-Lannelongue, France
Hypothesis
What is the relative contribution of inflammatory mediators in anti-IgE-induced contraction in human airways?
Conclusion
The study found that inflammatory mediators released during anti-IgE challenge can cause airway contraction, which may obscure the evaluation of the leukotriene component.
Supporting Evidence
- Human bronchial muscle preparations contracted when anti-IgE was added.
- Indomethacin enhanced the anti-IgE-induced contraction by 28%.
- BAY x1005 reduced the anti-IgE-induced contraction when combined with other treatments.
- The maximal response to anti-IgE was not modified by certain inhibitors.
- Inflammatory mediators may mask the evaluation of the leukotriene component.
Takeaway
When doctors test how certain substances affect breathing, they found that some chemicals can make it harder to see how other chemicals work.
Methodology
Human lung tissues were obtained from patients and tested for contraction responses to anti-IgE and various inhibitors.
Limitations
The study was limited to human lung tissues from patients with lung carcinoma, which may not represent all airway conditions.
Participant Demographics
Patients who underwent thoracotomy for lung carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website